The Pestilence of Pestell
Richard Pestell MB, BS, MD, PhD, FACP, FRACP. MBA, FRCP, FRSB, AO is the most dashing doctor a girl or a boy can ever dream of. What luck for Michael Lisanti to have been invited for a ride!
By Leonid Schneider, on research integrity, biomedical ethics and academic publishing
Richard Pestell MB, BS, MD, PhD, FACP, FRACP. MBA, FRCP, FRSB, AO is the most dashing doctor a girl or a boy can ever dream of. What luck for Michael Lisanti to have been invited for a ride!
The Schneider Rule teaches that if you wish to meet many science cheaters you must follow one of them.
“Poking around PubMed (Dysdera the spider is always on the hunt for new hornet’s nests) [..], I came across one image in two papers by Eliezer Masliah. […] By a conservative count, I contributed to about 160 out of 300 slides in the final dossier” – Mu Yang
Does being a science genius entitle you to sexual harassment, as academic authorities in Yale and elsewhere insist? Let’s look at papers by Michael Simons, Joseph Schlessinger and Arnold Levine.
“I have NEVER faked data. If you wish to carry on what appears to be a vendetta please supply me the name of your lawyer and I will have my lawyer contact him.” – Sal Pizzo, Duke University
Thomas Südhof, victim of racist and sexist persecution, announced to retract a second paper, “even though the quantitative analyses and conclusions are correct”.
“The Investigative Committee notes that the infractions to normal scientific conduct surveyed in this report were blatant and repeated. Dr. [XY] should be dealt with in a manner consistent to the flagrant nature of the misconduct and data manipulation.” 2004 Berkeley report, illegal in Germany
My review of the new book by Carl Elliott, “The Occasional Human Sacrifice”.
“My former and current lab members can attest that I have lectured the importance of scientific rigor and image rigor in our meetings several times each year.” – Andrew Z Wang
“MIT’s receipt and review of allegations of possible research misconduct by my office are treated as confidential under MIT and, to the extent applicable, federal policies. MIT does not intend to
disclose its receipt and review of these allegations to others. By the same token, you therefore may not disclose to others that you brought your concern to the VPR’s attention, or the outcome of MIT’s review of the concern.” Letter to Maarten van Kampen









